文献速递神经核医学肿瘤 PET/CT

同步高分辨率全脑磁共振波谱与[18F]FDG PET用于颞叶癫痫

Simultaneous high-resolution whole-brain MR spectroscopy and [18F]FDG PET for temporal lobe epilepsy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-10-12

本研究纳入48例耐药性内侧颞叶癫痫患者,在PET/MR一体机上同步采集高分辨率全脑MRSI与[18F]FDG PET。联合MRSI与PET视觉判读的侧化准确率为91.7%,高于常规MRI的52.1%;在23例MRI阴性患者中检出19例。联合海马NAA与FDG摄取的逻辑回归模型AUC为0.856,进一步纳入海马外区域后AUC升至0.939。

要点

  • 联合MRSI与[18F]FDG PET视觉判读侧化耐药性mTLE的准确率为91.7%,常规MRI为52.1%。
  • 23例MRI阴性mTLE中,联合MRSI与PET帮助检出19例。
  • 联合海马NAA与FDG摄取的模型AUC=0.856,加入杏仁核、丘脑、颞上回后AUC=0.939。

核心结论

  • 本文报告了首项使用同步高分辨率MRSI与[18F]FDG PET的代谢影像研究,有助于可视化MRI无法识别的病灶,并可能推进耐药性mTLE的诊断工具与管理策略。

研究设计与样本

  • 研究纳入48例耐药性mTLE患者(男/女31/17,年龄12-58岁),在PET/MR一体机上接受MRSI与[18F]FDG PET检查。
  • 通过视觉判读和代谢图统计分类器评估mTLE侧化,并与常规MRI比较。
  • 采用分层调节多元回归探讨疾病状态如何影响NAA改变与FDG摄取之间的关联。

主要发现

  • 高分辨率全脑MRSI提供的代谢物图分辨率与[18F]FDG PET相当。
  • 联合MRSI与[18F]FDG PET视觉判读在48例队列中mTLE侧化准确率为91.7%,高于常规MRI的52.1%。
  • 23例MRI阴性mTLE中,联合MRSI与[18F]FDG PET帮助检出19例。
  • 联合海马NAA水平与FDG摄取的逻辑回归模型改善侧化性能(AUC=0.856),进一步纳入杏仁核、丘脑和颞上回等海马外区域后AUC增至0.939。
  • 同步MRSI/PET显示病程和海马萎缩对海马NAA与葡萄糖摄取之间的关联具有调节影响。

关键数值与推荐

  • 联合MRSI与[18F]FDG PET视觉判读的mTLE侧化准确率为91.7%(48例队列),常规MRI为52.1%。
  • 23例MRI阴性mTLE中,联合MRSI与[18F]FDG PET帮助检出19例。
  • 联合海马NAA与FDG摄取的逻辑回归模型AUC=0.856;进一步纳入杏仁核、丘脑和颞上回后AUC=0.939。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Precise lateralizing the epileptogenic zone in patients with drug-resistant mesial temporal lobe epilepsy (mTLE) remains challenging, particularly when routine MRI scans are inconclusive (MRI-negative). This study aimed to investigate the synergy of fast, high-resolution, whole-brain MRSI in conjunction with simultaneous [18F]FDG PET for the lateralization of mTLE. METHODS: Forty-eight drug-resistant mTLE patients (M/F 31/17, age 12-58) underwent MRSI and [18F]FDG PET on a hybrid PET/MR scanner. Lateralization of mTLE was evaluated by visual inspection and statistical classifiers of metabolic mappings against routine MRI. Additionally, this study explored how disease status influences the associations between altered N-acetyl aspartate (NAA) and FDG uptake using hierarchical moderated multiple regression. RESULTS: The high-resolution whole-brain MRSI data offers metabolite maps at comparable resolution to [18F]FDG PET. Visual examinations of combined MRSI and [18F]FDG PET showed an mTLE lateralization accuracy rate of 91.7% in a 48-patient cohort, surpassing routine MRI (52.1%). Notably, out of 23 MRI-negative mTLE, combined MRSI and [18F]FDG PET helped detect 19 cases. Logistical regression models combining hippocampal NAA level and FDG uptake improved lateralization performance (AUC=0.856), while further incorporating extrahippocampal regions such as amygdala, thalamus, and superior temporal gyrus increased the AUC to 0.939. Concurrent MRSI/PET revealed a moderating influence of disease duration and hippocampal atrophy on the association between hippocampal NAA and glucose uptake, providing significant new insights into the disease's trajectory. CONCLUSION: This paper reports the first metabolic imaging study using simultaneous high-resolution MRSI and [18F]FDG PET, which help visualize MRI-unidentifiable lesions and may thus advance diagnostic tools and management strategies for drug-resistant mTLE.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Huang H, Zhang M, Zhao Y, et al. Simultaneous high-resolution whole-brain MR spectroscopy and [18F]FDG PET for temporal lobe epilepsy. Eur J Nucl Med Mol Imaging. 2023. PMID: 37823910. doi:10.1007/s00259-023-06465-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。